je.st
news
Tag: phase
Gaithersburg biotech expands into new research facility, preps for last phase of drug trials
2015-06-04 22:27:14| Biotech - Topix.net
Gaithersburg-based Novavax Inc. - known for its work developing vaccine candidates for the flu, a pediatric respiratory illness and Ebola - expanded into a new 54,000-square-foot research and development space where it plans to house its vaccine work. "It's a very important signal of our continued growth," said Buck Phillips , chief financial officer of Novavax of the new space at 21 Firstfield Road, across the street from its headquarters.
First Phase Nearly Complete on Washington National Cathedral Repairs
2015-06-04 20:25:56| ENR.com: Headline News
Initial $10-million, four-year effort sets stage for program focused on the exterior.
Tags: complete
national
washington
phase
DNV GL JIP Investigates Accuracy of Flow Meter Technology for Phase Contaminated Oil Flows
2015-06-03 11:02:00| Offshore Technology
Accurate allocation measurement results are a key financial and commercial driver for E&P companies. Yet despite limited evidence of the performance of Coriolis and ultrasonic flow meter technology, they are being increasingly deployed for single pha
Tags: technology
flow
accuracy
oil
Ichor Partner Scancell Announces Update on SCIB1 Phase 1/2 Clinical...
2015-06-02 21:34:40| Logistics - Topix.net
Ichor Medical Systems, Inc. is pleased to announce that their partner Scancell Holdings plc presented updated and very encouraging data from the ongoing Phase 1/2 clinical trial of SCIB1, its DNAi 1 2ImmunoBody being developed for the treatment of patients with melanoma, at the American Society of Clinical Oncology meeting in Chicago. The trial is ani 1 2open label, non-randomized study to characterize the safety and tolerability of SCIB1 administeredi 1 2using Ichor's TriGridTM delivery system, as well as provide initial assessment of the ability of SCIB1 to delay ori 1 2prevent disease recurrence in patients with Stage III/IV melanoma.
Tags: partner
update
phase
clinical
Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial ...
2015-06-01 20:27:17| Biotech - Topix.net
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has begun enrolling patients in a Phase 2b clinical trial to evaluate Apricus' novel product candidate, fispemifene, a selective estrogen receptor modulator , for the treatment of men with symptomatic secondary hypogonadism also known as low testosterone. The Phase 2 proof-of-concept clinical trial is a randomized, double-blind, placebo-controlled, parallel arm, multi-center study in approximately 160 hypogonadal men aged 18 to 64 who present with sexual dysfunction related to secondary hypogonadism, or low levels of testosterone.
Tags: trial
phase
patients
clinical
Sites : [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] next »